Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Ballad Health warned clients of possible exposures to hepatitis B and C as well as HIV but said the risk was “extremely low.” [VIDEO]
Barriers still stand in the way of making treatment available to all who need it.
Hepatitis B and C kill more people each year than HIV/AIDS, malaria and TB. That’s why “Hepatitis Can’t Wait.”
Previous studies of the association between tenofovir and the coronavirus have yielded mixed results.
Despite a surge in HIV cases linked to injection drug use, the syringe exchange regulations were to take effect July 9.
An extra booster dose raised antibody levels in one third of people with organ transplants, but many remain unprotected.
Previous studies of the association between tenofovir and COVID-19 outcomes in people with HIV have yielded mixed results.
Suppression of hepatitis B virus with antiviral treatment lowered the risk of hepatocellular carcinoma by 58%.
After my treatment interruption I’m... undetectable, in every way. Untransmittable, that’s how I’ll stay (hopefully!).
2019 HIV cases were the lowest since 1990, and hepatitis B rates also fell, according to a WHO report. But most STIs peaked.
Over 2.3 million people have hep C in the United States. The liver disease can be cured—but first, you must know your status.
HIV was linked to an increased prevalence of liver fibrosis in a recent study.
About 2.4 million Americans are living with hepatitis C and 862,000 have hep B. Spread the word about this hidden epidemic.
HIV, hepatitis and opioids take a toll on West Virginia. $2.4 million in federal aid arrives amid battles over syringe exchanges.
If left untreated, hepatitis B and C can lead to cirrhosis and liver cancer.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.